First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Bumrungrad Hospital Public: the story is balanced — International patient volume and mix - Middle Eastern patients (25-30% of international) generate 2-3x revenue per visit…
★ Analysts see FY2027 revenue reaching $27.0B — +5.7% growth in a single year.
What Moves the Stock
1International patient volume and mix - Middle Eastern patients (25-30% of international) generate 2-3x revenue per visit versus Asian patients; geopolitical stability in source markets directly impacts quarterly results
2Thai baht exchange rate movements - 55-60% revenue from foreign patients creates FX sensitivity; stronger baht reduces affordability for medical tourists and compresses USD-equivalent revenues
3Medical tourism policy changes - visa regulations, health insurance portability, and government medical tourism promotion programs in Thailand and source countries
4Capacity utilization rates and average revenue per patient - occupancy above 85% signals pricing power; ARPPU growth indicates favorable case mix toward high-acuity procedures
5Inpatient services (estimated 50-55% of revenue): surgical procedures, ICU care, complex treatments with multi-day stays
growth-at-reasonable-price (GARP) - 26.3% ROE and 30.2% net margins attract quality-focused investors…
Low direct sensitivity given zero debt/equity ratio and $8.7B operating cash flow generation eliminates financing cost exposure.
Watch on earnings: Thai baht to USD exchange rate (DEXTHUS) - directly impacts medical tourism affordability and revenue translation, Brent crude oil prices - Middle Eastern patient volumes (25-30% of international) correlate with oil-driven GDP growth in GCC countries, Thailand international tourist arrivals - leading indicator for medical tourism demand; medical tourists represent 5-8% of total visitors.
One Sentence Summary:
Bumrungrad Hospital Public: the story is balanced — international patient volume and mix - middle eastern patients (25-30% of international) generate 2-3x revenue per visit versus asian.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.